Year of Award:
Molecular & Cellular Analysis Technologies
Other PI or Project Leader:
N-ABL THERAPEUTICS, INC.
The ability to monitor and measure protein kinase activity in tumorigenesis and cancer can be indicative of and critical to the transformation process and therefore represents an attractive diagnostic strategy, with a multi-billion dollar market opportuni